OpenAlex
PricingAboutJobs
Log inGet started
Work

Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease

HTML

Year: 2013
Type: article
Source: Journal of Pharmacy and Pharmacology
DOI: 10.1111/jphp.12148
Authors: Jayasankar Kosaraju, Vishakantha Murthy, Rizwan Basha Khatwal, Anil Dubala, Santhivardhan Chinni, Satish Kumar Muthureddy Nataraj, Duraiswamy Basavan
Institutions: JSS Academy of Higher Education and Research, JSS College of Pharmacy, Mayo Clinic
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: vildagliptin, Alzheimer's disease, DPP-4 inhibitors, glucagon-like peptide-1, streptozotocin-induced Alzheimer's disease model, memory retention, amyloid-beta, tau phosphorylation, neuroinflammation, hippocampus, cognitive impairment, type 2 diabetes
SDG: Good health and well-being

Open Access status: closed

Funders: University of Pennsylvania, Wake Forest University, Pennsylvania State University, Council of Scientific and Industrial Research, India, University of Sydney, Penn State College of Medicine
OpenAlex ID: W1892163767
FWCI: 3.076
Cites: 53
Cited by: 157
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security